High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study

MLA

Enrico Pogliani, et al. “High Response Rate and Improvement of Long-Term Survival with Combined Treatment Modalities in Patients with Poor-Risk Primary Thyroid Diffuse Large B-Cell Lymphoma: An International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi Study.” Leukemialymphoma, vol. 52, no. 5, Feb. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8c89b927e33d0d3447590ace0b292065&authtype=sso&custid=ns315887.

APA

Enrico Pogliani, Monica Bellei, Maurizio Martelli, Richard W. Tsang, Sergio Cortelazzo, Gianluca Gaidano, Stefano Luminari, Andrea Rossi, Franco Cavalli, Elena Oldani, Armando López-Guillermo, Massimo Federico, Mary Gospodarowicz, Annarita Conconi, Michael Mian, Mario Busetto, Emanuele Zucca, Maria Elena Cabrera, Alessandro Rambaldi, & Fausto Rossini. (2011). High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study. Leukemialymphoma, 52(5).

Chicago

Enrico Pogliani, Monica Bellei, Maurizio Martelli, Richard W. Tsang, Sergio Cortelazzo, Gianluca Gaidano, Stefano Luminari, et al. 2011. “High Response Rate and Improvement of Long-Term Survival with Combined Treatment Modalities in Patients with Poor-Risk Primary Thyroid Diffuse Large B-Cell Lymphoma: An International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi Study.” Leukemialymphoma 52 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8c89b927e33d0d3447590ace0b292065&authtype=sso&custid=ns315887.